Merit Financial Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Merit Financial Group’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-27,613	Closed	-$868K	–	2453
2026 Q2	$868K	Sell	27,613 -782	-3%	-$23.1K	0.01%	1157
2026 Q1	$703K	Buy	28,395 +394	+1%	+$9.39K	0.01%	1169
2025 Q4	$654K	Buy	+28,001	New	+$624K	0.01%	1139

Other funds holding CPRX

Teacher Retirement System of Texas Austin, Texas $37.3B AUM 26.21% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Merit Financial Group's CPRX Position: Q3 2026 in Review

Merit Financial Group sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 27,613 shares — an estimated $868K sold.

Merit Financial Group first reported a position in CPRX in Q4 2025 and held it in 3 quarters. The position peaked at $868K in Q2 2026. 3 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

Merit Financial Group reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
Merit Financial Group sold 27,613 Catalyst Pharmaceutical shares in Q3 2026, an estimated $868K.
Merit Financial Group first reported a position in Catalyst Pharmaceutical in Q4 2025 and held it in 3 quarters.
Merit Financial Group's Catalyst Pharmaceutical position peaked at $868K in Q2 2026.
3 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.